Innovate UK is streaming funds into a £1-million artificial intelligence (AI) research project to be delivered by the Medicines Discovery Catapult and two Cambridge-based firms with expertise in software/machine learning.
Actelion has unveiled new data showing that the first ever randomised, controlled clinical trial investigating Opsumit as potential treatment for portopulmonary hypertension (PoPH) hit its primary target.
The National Institute for Health and Care Excellence has backed NHS funding for Novartis’ oral targeted adjuvant combination therapy Tafinlar and Mekinist, offering new hope to patients with a specific type of skin cancer.
Medical Science Liaison of the Year has been expanded to include three levels of seniority and forms the backbone of the all new Medical and Scientific Excellence Awards, alongside categories for scientific advisors and medical information professionals.
Alarm bells over the NHS’ ability to cope with looming winter pressures are ringing again after some aspects of service performance sunk to new lows in the summer, with record waiting times for A&E and cancer treatment.